Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.
Micron Biomedical has raised $16.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Micron Biomedical's investors include Bill & Melinda Gates Foundation, J2 Ventures, LTS Lohmann Therapie-Systeme AG, Global Health Investment Corporation, GRA Venture Fund.
Micron Biomedical is headquartered in Atlanta, United States.
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.
Micron Biomedical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Micron Biomedical — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/micron-biomedical. Accessed July 31, 2026.
VCBacked. (2025). Micron Biomedical — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/micron-biomedical
{{cite web |title=Micron Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/micron-biomedical |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated